Management has been pivoting the company's operations to widen Docusign's scope and diversify its revenue options. It now focuses more on helping companies manage contracts. It's not only a good way to grow sales but also potentially make its business more sustainable and safer in the long run. Docusign desperately needs a catalyst Artificial intelligence is going to be an important part of the company's growth strategy moving forward. Docusign (DOCU 2.41%) stock has crashed by 80% in the past three years. ...

Strong cash flow is encouraging, but decelerating growth is deeply troubling. Docusign's market capitalization peaked above $61 billion in 2021. This was way too high for a company that had less than $2 billion in annual sales at the time. Trailing-12-month revenue increased to $2.8 billion, but this growth hasn't been fast enough to meet previous expectations. Businesses with annual revenue growth at a mid-single-digit percentage can still produce market-beating gains for patient investors if they have hea ...

Previous rating DocuSign (NASDAQ:DOCU) reported better than expected first fiscal quarter results, which were released on June 6, 2024. The e-Signature leader reported slowing top-line growth, which was expected, and also revealed persistent risks to its dollar net retention rate, a key performance metric for software companies. Although DocuSign is facing challenges in terms of customer monetization, I believe the e-Signature company could be an attractive investment due to its strong free cash flows and h ...

Teladoc Health (TDOC) Additionally, Q1 2024 saw a 9% YoY boost in chronic care enrollment, a critical component of the integrated care sector. The boost demonstrates the ongoing interest in and demand for Teladoc's services. The segment's adjusted EBITDA margin increased by 2.6% to 12.6%, marking increased profitability and operational leverage within the integrated care business. DocuSign (NASDAQ:DOCU) optimizes procedures for clients and enterprises by enabling digital agreements and document signing. The ...

Docusign is the undisputed leader in its space, but can it keep that lead? E-signature company Docusign (DOCU -0.66%) is one of these businesses. In 2020, the stock rose by 200% as investors piled into any company that might benefit from the need for social distancing. Certainly, there was high demand for the ability to sign documents electronically in those early days of the pandemic. 2021 was a different year for Docusign -- the stock fell 31%, and today, shares trade nearly 83% below their early 2021 pea ...

Earnings Estimate Revisions Shares of this provider of electronic signature technology have returned -16.1% over the past month versus the Zacks S&P 500 composite's +4% change. The Zacks Technology Services industry, to which DocuSign belongs, has gained 5.7% over this period. Now the key question is: Where could the stock be headed in the near term? Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair val ...

Docusign was originally the world's largest e-signature company. Then it built the Agreement Cloud, a collection of dozens of digital applications designed to manage the entire contract life cycle, from drafting to negotiating to closing. It helped the company scale to more than 1 billion users worldwide, with over 1.5 million paying customers. Docusign is quietly putting together an incredibly bullish case for its stock. Docusign shares still trade about 83% below their all-time high, but they now look che ...

DocuSign, Inc. (DOCU) reported impressive first-quarter fiscal 2025 results, wherein both earnings and revenues beat the Zacks Consensus Estimate. The better-than-expected results, however, failed to impress the market as the stock declined 6.6% since the earnings release on Jun 6. Quarterly EPS of 82 cents per share surpassed the Zacks Consensus Estimate by 3.8% and increased 13.9% from the year-ago fiscal quarter. Total revenues of $709.6 million beat the consensus mark by a slight margin and improved 7.3 ...

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends DocuSign. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

DocuSign (NASDAQ:DOCU)'s stock dipped by more than 3% despite a better-than-expected 1Q FY2025 earnings report. A slightly negative reaction without triggering a significant selloff might indicate a muted result that disappoints investors. In my previous coverage, I issued a hold rating and discussed a potential value trap for the stock due to a growth slowdown to low teen digits. After a year, the stock has been trading on the sidelines and is currently down 8% since my last article, compared to a more tha ...